(Q36465915)

14 August 2017

Phase II study of the thymidylate synthetase inhibitor CB3717 (N10-propargyl-5,8-dideazafolic acid) in colorectal cancer (English)

1 reference

https://api.crossref.org/works/10.1038/BJC.1988.143

14 August 2017

1 reference

1 reference

7 January 2023

4

A. L. Harris

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3408648

7 January 2023

author name string

M. J. Harding

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3408648

7 January 2023

B. M. Cantwell

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3408648

7 January 2023

R. A. Milstead

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3408648

7 January 2023

S. B. Kaye

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3408648

7 January 2023

language of work or name

English

0 references

publication date

1 June 1988

1 reference

PMCID

2246458

full work available at URL

14 August 2017

https://europepmc.org/articles/PMC2246458

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3408648

https://europepmc.org/articles/PMC2246458?pdf=render

7 January 2023

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3408648

http://www.nature.com/articles/bjc1988143.pdf

7 January 2023

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/BJC.1988.143

http://www.nature.com/articles/bjc1988143

7 January 2023

1 reference

https://api.crossref.org/works/10.1038/BJC.1988.143

British Journal of Cancer

7 January 2023

published in

1 reference

14 August 2017

57

1 reference

14 August 2017

628-629

1 reference

14 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1988.143

14 August 2017

0 references

cites work

A phase I evaluation of the quinazoline antifolate thymidylate synthase inhibitor, N10-propargyl-5,8-dideazafolic acid, CB3717

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246458

A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma

30 September 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246458

Modulation of 5-fluorouracil metabolism and cytotoxicity by antimetabolite pretreatment in human colorectal adenocarcinoma HCT-8

30 September 2017

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3408648

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A potent antitumour quinazoline inhibitor of thymidylate synthetase: Synthesis, biological properties and therapeutic results in mice

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3408648

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/BJC.1988.143

1 reference

14 August 2017

1 reference

14 August 2017

1 reference

PMCID

2246458